Andriyan Grinev

Andriyan Grinev

Auto-generated profile, based on publicly available information

Andriyan Grinev

Laboratory of Emerging Pathogens (LEP), Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CCCaren Chancey
Caren Chancey
AGAndriyan Grinev
Andriyan Grinev
EVEvgeniya Volkova
Evgeniya Volkova
MRMaria Rios
Maria Rios
Since its initial isolation in Uganda in 1937 through the present, West Nile virus (WNV) has become an important cause of human and animal disease worldwide. WNV, an enveloped virus of the genusFlavivirus, is naturally maintained in an enzootic cycle between birds and mosquitoes, with occasional epizootic spillover causing disease in humans and horses. The mosquito vectors for WNV are widely distributed worldwide, and the known geographic range of WNV transmission and disease has continued to increase over the past 77 years. While most human infections with WNV are asymptomatic, severe neurological disease may develop resulting in long-term sequelae or death. Surveillance and preventive measures are an ongoing need to reduce the public health impact of WNV in areas with the potential for transmission.

1 January 2017 in Journal of Virological Methods
Verified
Journal Article
Closed access
AGAndriyan Grinev
Andriyan Grinev
CCCaren Chancey
Caren Chancey
EVEvgeniya Volkova
Evgeniya Volkova
VCVladimir Chizhikov
Vladimir Chizhikov
MRMaria Rios
Maria Rios